Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many Integrated Care Boards have produced plans for transitioning responsibility for the delivery of post-exposure treatments for Covid-19 from Covid-19 Medicine Delivery Units.

NHS England is working closely with local health systems and supporting integrated care boards (ICBs) to develop service delivery plans which ensure continued timely access to assessment and treatment for COVID-19 that meet the needs of their local populations. To support the transition away from pandemic-specific arrangements NHS England is regularly engaging with charities, patient groups and other stakeholders to understand where national and local action may be required to ensure transition readiness. The NHS will continue to communicate to people most vulnerable to COVID-19 about available clinical interventions, including vaccination and treatments, as well as testing and public health advice.

ICBs are responsible for the continued delivery of COVID-19 treatments, including where appropriate transitioning the delivery of community-based COVID-19 treatments away from COVID-19 Medicine Delivery Units to routine care pathways by the end of this month. ICBs have the flexibility to create a routine patient access pathway that best meets local needs and circumstances, including for immunocompromised patients.

ICBs are responsible for their own plans and commissioning schedules. This information is not held centrally by the department.